John T. Fleming's most recent trade in Usana Health Sciences Inc was a trade of 500 Common Stock done at an average price of $29.7 . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Usana Health Sciences Inc | John T. Fleming | Director | Sale of securities on an exchange or to another person at price $ 29.66 per share. | 09 Jun 2025 | 500 | 4,200 (0%) | 0% | 29.7 | 14,829 | Common Stock |
| Usana Health Sciences Inc | John T. Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 4,230 | 4,230 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 674 | 0 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2025 | 674 | 4,700 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Sale of securities on an exchange or to another person at price $ 33.30 per share. | 11 Mar 2025 | 500 | 4,026 (0%) | 0% | 33.3 | 16,648 | Common Stock |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2025 | 674 | 4,526 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2025 | 674 | 674 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 675 | 1,348 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 675 | 3,852 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 674 | 2,023 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2024 | 674 | 3,177 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Sale of securities on an exchange or to another person at price $ 44.43 per share. | 31 Jul 2024 | 1,000 | 2,503 (0%) | 0% | 44.4 | 44,430 | Common Stock |
| Usana Health Sciences Inc | John T. Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 2,697 | 2,697 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2024 | 490 | 0 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2024 | 490 | 3,503 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Sale of securities on an exchange or to another person at price $ 48.99 per share. | 04 Mar 2024 | 300 | 3,013 (0%) | 0% | 49.0 | 14,696 | Common Stock |
| Usana Health Sciences Inc | Fleming T. John | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2024 | 491 | 490 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2024 | 491 | 3,313 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | Fleming T. John | Director | Sale of securities on an exchange or to another person at price $ 49.73 per share. | 12 Dec 2023 | 312 | 2,822 (0%) | 0% | 49.7 | 15,515 | Common Stock |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2023 | 490 | 981 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Oct 2023 | 490 | 3,134 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2023 | 491 | 1,471 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jul 2023 | 491 | 2,644 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Sale of securities on an exchange or to another person at price $ 67.04 per share. | 05 May 2023 | 1,250 | 2,153 (0%) | 0% | 67.0 | 83,804 | Common Stock |
| Usana Health Sciences Inc | John T. Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2023 | 1,962 | 2,366 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2023 | 404 | 1,962 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Apr 2023 | 404 | 3,403 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 404 | 404 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 404 | 2,999 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2022 | 404 | 808 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2022 | 404 | 2,595 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 404 | 1,212 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 404 | 2,191 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2022 | 1,616 | 1,928 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 312 | 1,787 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Apr 2022 | 312 | 1,616 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 312 | 1,475 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 312 | 312 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2021 | 312 | 1,163 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2021 | 312 | 624 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | John T. Fleming | Director | Sale of securities on an exchange or to another person at price $ 97.26 per share. | 30 Aug 2021 | 300 | 851 (0%) | 0% | 97.3 | 29,178 | Common Stock |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 312 | 936 | - | - | Restricted Stock Units | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jul 2021 | 312 | 1,151 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2021 | 1,248 | 1,667 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 419 | 1,248 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2021 | 419 | 839 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 420 | 419 | - | - | Restricted Stock Unit | |
| Usana Health Sciences Inc | John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2021 | 420 | 420 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | John T. Fleming | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2020 | 839 | 839 | - | - | Restricted Stock Unit |